Literature DB >> 26135958

Roles of A20 in autoimmune diseases.

Min Zhang1, Ling-Long Peng2, Ying Wang3, Jian-Shu Wang3, Jiao Liu3, Meng-Meng Liu3, Jia Hu3, Bin Song3, Hai-Bing Yang4.   

Abstract

A20 (TNFAIP3), known to inhibit NF-κB function by deubiquitinating-specific NF-κB signaling molecules, has been found in many cell types of the immune system. Recent findings suggest that A20 is essential for the development and functional performance of dendritic cell, B cell, T cell and macrophage. A number of studies further demonstrate that these cells are crucial in the pathogenesis of autoimmune diseases, such as type 1 diabetes, systemic lupus erythematosus, inflammatory bowel disease, ankylosing arthritis, Sjögren's syndrome and rheumatoid arthritis. In this article, we focus on the recent advances on the roles of A20 in autoimmune diseases and discuss the therapeutic significance of these new findings.

Entities:  

Keywords:  A20 (TNFAIP3); Autoimmune diseases; Autoimmunity; Immune cells

Mesh:

Substances:

Year:  2016        PMID: 26135958     DOI: 10.1007/s12026-015-8677-6

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  42 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  A20: central gatekeeper in inflammation and immunity.

Authors:  Beatrice Coornaert; Isabelle Carpentier; Rudi Beyaert
Journal:  J Biol Chem       Date:  2008-11-13       Impact factor: 5.157

3.  A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies.

Authors:  Nadine Hövelmeyer; Sonja Reissig; Nguyen Thi Xuan; Petra Adams-Quack; Dominika Lukas; Alexei Nikolaev; Dirk Schlüter; Ari Waisman
Journal:  Eur J Immunol       Date:  2011-02-10       Impact factor: 5.532

4.  Down-regulation of A20 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

Authors:  Di Li; Lei Wang; Yuchen Fan; Lijun Song; Chun Guo; Faliang Zhu; Lining Zhang; Yongyu Shi
Journal:  J Clin Immunol       Date:  2012-08-17       Impact factor: 8.317

5.  The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity.

Authors:  Rita M Tavares; Emre E Turer; Chih L Liu; Rommel Advincula; Patrizia Scapini; Lesley Rhee; Julio Barrera; Clifford A Lowell; Paul J Utz; Barbara A Malynn; Averil Ma
Journal:  Immunity       Date:  2010-08-12       Impact factor: 31.745

6.  B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice.

Authors:  Yuanyuan Chu; J Christoph Vahl; Dilip Kumar; Klaus Heger; Arianna Bertossi; Edyta Wójtowicz; Valeria Soberon; Dominik Schenten; Brigitte Mack; Miriam Reutelshöfer; Rudi Beyaert; Kerstin Amann; Geert van Loo; Marc Schmidt-Supprian
Journal:  Blood       Date:  2010-11-18       Impact factor: 22.113

Review 7.  RANKL-RANK signaling in osteoclastogenesis and bone disease.

Authors:  Teiji Wada; Tomoki Nakashima; Nishina Hiroshi; Josef M Penninger
Journal:  Trends Mol Med       Date:  2005-12-13       Impact factor: 11.951

8.  A pro-inflammatory role for A20 and ABIN family proteins in human fibroblast-like synoviocytes in rheumatoid arthritis.

Authors:  Hideya Igarashi; Ayano Yahagi; Taro Saika; Jun Hashimoto; Tetsuya Tomita; Hideki Yoshikawa; Katsuhiko Ishihara
Journal:  Immunol Lett       Date:  2011-11-09       Impact factor: 3.685

9.  The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.

Authors:  David L Boone; Emre E Turer; Eric G Lee; Regina-Celeste Ahmad; Matthew T Wheeler; Colleen Tsui; Paula Hurley; Marcia Chien; Sophia Chai; Osamu Hitotsumatsu; Elizabeth McNally; Cecile Pickart; Averil Ma
Journal:  Nat Immunol       Date:  2004-08-29       Impact factor: 25.606

10.  Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factor-induced toxicity and experimental colitis.

Authors:  Lars Vereecke; Mozes Sze; Conor Mc Guire; Brecht Rogiers; Yuanyuan Chu; Marc Schmidt-Supprian; Manolis Pasparakis; Rudi Beyaert; Geert van Loo
Journal:  J Exp Med       Date:  2010-06-07       Impact factor: 14.307

View more
  12 in total

Review 1.  Genomics, Biology, and Human Illness: Advances in the Monogenic Autoinflammatory Diseases.

Authors:  Hirotsugu Oda; Daniel L Kastner
Journal:  Rheum Dis Clin North Am       Date:  2017-08       Impact factor: 2.670

2.  A20 Orchestrates Inflammatory Response in the Oral Mucosa through Restraining NF-κB Activity.

Authors:  Yajie Li; Erin C Mooney; Sara E Holden; Xia-Juan Xia; David J Cohen; Scott W Walsh; Averil Ma; Sinem E Sahingur
Journal:  J Immunol       Date:  2019-02-13       Impact factor: 5.422

3.  Decreased A20 expression on circulating CD56bright NK cells contributes to a worse disease status in patients with ankylosing spondylitis.

Authors:  M Yang; Y Zhou; L Liu; S Wang; J Jiang; Q Shang; H Yu; X Xiang; X Pang; T Li; P Zhao
Journal:  Clin Exp Immunol       Date:  2019-06-30       Impact factor: 4.330

4.  A20 Restores Impaired Intestinal Permeability and Inhibits Th2 Response in Mice with Colitis.

Authors:  Donghui Chen; Li Ma; Tianyong Hu; Jiangqi Liu; Baohui Chen; Pingchang Yang; Zhiqiang Liu
Journal:  Dig Dis Sci       Date:  2019-10-04       Impact factor: 3.199

5.  A20 inhibits lipopolysaccharide-induced inflammation in enterocytes.

Authors:  Cui-Fang Zheng; Jie-Ru Shi; Ying Huang; Sheng-Nan Wang
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-11-06

6.  Loss of A20 in BM-MSCs regulates the Th17/Treg balance in Rheumatoid Arthritis.

Authors:  Zhuan Feng; Yue Zhai; Zhaohui Zheng; Lijie Yang; Xing Luo; Xiwen Dong; Qing Han; Jin Jin; Zhi-Nan Chen; Ping Zhu
Journal:  Sci Rep       Date:  2018-01-11       Impact factor: 4.379

7.  Altered expression of A20 gene in peripheral blood mononuclear cells is associated with the progression of chronic hepatitis B virus infection.

Authors:  Yu-Chen Fan; Yuan-Yuan Zhang; Yan-Yan Sun; Na Wang; Xiao-Yan Xiao; Kai Wang
Journal:  Oncotarget       Date:  2016-10-18

Review 8.  NFκB and Kidney Injury.

Authors:  Ning Song; Friedrich Thaiss; Linlin Guo
Journal:  Front Immunol       Date:  2019-04-16       Impact factor: 7.561

9.  Overexpression of the ubiquitin-editing enzyme A20 in the brain lesions of Multiple Sclerosis patients: moving from systemic to central nervous system inflammation.

Authors:  Simona Perga; Francesca Montarolo; Serena Martire; Brigitta Bonaldo; Gabriele Bono; Jessica Bertolo; Roberta Magliozzi; Antonio Bertolotto
Journal:  Brain Pathol       Date:  2020-11-18       Impact factor: 6.508

10.  Characterization of Cellular Heterogeneity and an Immune Subpopulation of Human Megakaryocytes.

Authors:  Cuicui Liu; Dan Wu; Meijuan Xia; Minmin Li; Zhiqiang Sun; Biao Shen; Yiying Liu; Erlie Jiang; Hongtao Wang; Pei Su; Lihong Shi; Zhijian Xiao; Xiaofan Zhu; Wen Zhou; Qianfei Wang; Xin Gao; Tao Cheng; Jiaxi Zhou
Journal:  Adv Sci (Weinh)       Date:  2021-05-26       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.